Termeer Interview on Genzyme's Accord With Icahn

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

June 14 (Bloomberg) -- Henri Termeer, chief executive officer of Genzyme Corp., talks with Bloomberg's Lori Rothman about the company’s agreement with billionaire investor Carl Icahn to settle a proxy contest. Termeer also discusses the prospects for Genzyme and the biotechnology industry. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change